958245-17-5 Usage
General Description
1-(2-methoxy-4-nitrophenyl)-4-methyl-1H-imidazole is a chemical compound with the molecular formula C10H10N4O3. It is a derivative of imidazole, a five-membered heterocyclic ring containing two non-adjacent nitrogen atoms. The compound contains a 1-methyl-4-imidazole ring with a 2-methoxy-4-nitrophenyl group attached to it. This chemical is commonly used in pharmaceutical research and development, particularly in the search for new drugs with potential anti-inflammatory, antibacterial, or antifungal properties. Its precise biological activity and pharmacological potential have yet to be fully elucidated, though its unique structure makes it a promising candidate for further investigation and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 958245-17-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,8,2,4 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 958245-17:
(8*9)+(7*5)+(6*8)+(5*2)+(4*4)+(3*5)+(2*1)+(1*7)=205
205 % 10 = 5
So 958245-17-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H11N3O3/c1-8-6-13(7-12-8)10-4-3-9(14(15)16)5-11(10)17-2/h3-7H,1-2H3
958245-17-5Relevant articles and documents
FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF
-
Paragraph 0321, (2017/05/14)
The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.
FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF
-
Paragraph 0303, (2015/08/03)
The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.
NOVEL SUBSTITUTED TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS
-
Page/Page column 28-29, (2012/12/13)
The present invention is concerned with novel substituted triazole derivatives of Formula (I) wherein Het1, R1, R2, A1, A2, A3, A4, L1, and L2 have the mean